medigraphic.com
ISSN 2078-7162 (Print)

2021, Number 2

Next >>

Rev Cub de Med Fis y Rehab 2021; 13 (2)

Description of bone metastases by scintigraphy

Rodríguez PL, López MK, Menéndez PR, Ortiz RJ, León CR

Language: Spanish
References: 21
Page: 1-15
PDF size: 550.53 Kb.


ABSTRACT

Introduction: Bone metastasis is the most frequent malignant disease that affects bone and it is responsible for most of the morbidity and mortality of malignant tumor disease.
Objective: To describe bone metastases from the scintigraphic point of view in a group of patients.
Methods: A retrospective and descriptive study was developed in the Nuclear Medicine service at Hermanos Ameijeiras Hospital for the patients treated for clinical and histological diagnosis of cancer, who underwent bone scan as part of their admission from January 2018 to December 2018.
Results: The prevalence of bone metastasis obtained was 33%. In this sense, the male patients were more affected (35.37%) than female ones (29.44%). The most frequent primary site in the group with evidence of bone metastases was prostate (52.38%), followed by breast (27.81%) and lung (5.52%). A total of 145 patients (84%) had pain. The part of the body where metastases were most frequently detected was the spine (26.20%), followed by thorax (20.6%) and pelvis (18, 22%).
Conclusions: Bone scintigraphy, as a functional study, made it possible to early evaluate the presence of bone metastases in patients where pain was a predominant symptom, critically affecting the quality of life of each one of them.


REFERENCES

  1. Álvarez A, Soto S, García Y. Metástasis óseas: enfoque ortopédico. AMC. 2019 [acceso 10/02/2020];23(1):144-154. Disponible en: http://revistaamc.sld.cu/index.php/amc/article/view/5833

  2. Siegel RL, Miller KD, Jernal A. Cancer statistics. 2017. CA Cancer J Clin. 2017 [acceso 14/03/2019];67:7-30. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28055103/

  3. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006 [acceso 21/03/2019];6243-9. Disponible en: https://clincancerres.aacrjournals.org/content/12/20/6243s

  4. Feller L, Kramer B, Lemmer J. A short account of metastatic bone disease. Cancer Cell Int. 2011 [acceso 11/02/2019];11:24. Disponible en: https://cancerci.biomedcentral.com/articles/10.1186/1475-2867-11-24

  5. Doddala SM, Suryadevara A, Chinta SK, Madisetty AL. Incidence and pattern of bone metastases at presentation in Indian carcinoma breast patients. Indian J Cancer. 2016 [acceso 25/03/2019];53(3):360-2. Disponible en: https://www.researchgate.net/publication/316699363_Incidence_and_pattern_of_bone_metastases_at_presentation_in_Indian_carcinoma_breast_patients_PMID_28244457

  6. Coleman RE. Skeletal complications of malignancy. Cancer 1997 [acceso 25/05/2019];80(Suppl):1588-1594. Disponible en: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0142(19971015)80:8+%3C1588:AID-CNCR9%3E3.0.CO;2-G

  7. Qureshi A, Shams U. Metastatic Bone Disease as Seen in Our Clinical Practice . Experience at a Tertiary Care Cancer Center in Pakistan. Asian Pacific J Cancer Prev. 2012 [acceso 24/06/2019];13:4369. Disponible en: https://www.researchgate.net/publication/233736460_Metastatic_Bone_Disease_as_Seen_in_Our_Clinical_Practice__Experience_at_a_Tertiary_Care_Cancer_Center_in_Pakistan

  8. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone Imaging in Metastatic Breast Cancer. Journal of Clinical Oncology. 2004 [acceso 25/08/2019];22:2942-53. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15254062/

  9. Memon AG, Jaleel A, Aftab J. Patten of prostatic carcinoma metastases in bones detected by bone scans using Technitium 99m methyl dipohsphate (Tc99m MDP) imaging technique. Pak J Med Sci. 2006 [acceso 23/08/2019];22:180-3. Disponible en: https://pjms.com.pk/issues/aprjun06/article/article18.html

  10. Vahid Reza Dabbagh Kakhki, Kazem Anvari.Pattern and distribution of bone metastases in common malignant tumors. Nuclear Medicine Review. 2013 [acceso 11/09/2019];16(2):66-9. Disponible en: https://journals.viamedica.pl/nuclear_medicine_review/article/view/NMR.2013.0037/34332

  11. Kardamakis D, Vassiliou V, Chow Edward. Bone metastases. A translational and clinical approach. Cancer metastases, biology and treatment. 2009 [acceso 12/06/2019];12:137-160. Disponible en: https://www.springer.com/gp/book/9781402098185

  12. Langsteger W, Rezaee A, Pirich C, Beheshti M. 18F-NaF-PET/CT and 99mTcMDP bone scintigraphy in the detection of bone metastases in prostate cancer. Semin Nucl Med. 2016 [acceso 12/9/2019];46:491-501. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27825429/

  13. Garballo A, Villafranca E. Enfermedad metastásica ósea. Diagnóstico y tratamiento. An. Sist. Sanit. Navar. 2004 [acceso 26/10/2019];27(Supl. 3):137-153. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137

  14. Li S, Peng Y, Weinhandl E, Blaes A, Cetin K, Chia V, et al Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clinical Epidemiology 2012 [acceso 05/05/2019];4:87-93. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22570568/

  15. López-Abente G, Pollán M, Aragonés N, Pérez Gómez B, Hernández Barrera V, Lope V, et al. Situación del cáncer en España: incidencia. An Sist Sanit Navar 2004 [acceso 10/11/2019];27:165-73. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137

  16. Yavas O, Hayran M, Ozisik Y. Factors affecting survival in breast cancer patients following bone metastasis. Tumori. 2007 [acceso 02/02/20];93:580-6. Disponible en: https://www.researchgate.net/publication/5514818_Factors_Affecting_Survival_in_Breast_Cancer_Patients_following_Bone_Metastasis

  17. Tsuya A, Fukuoka M. Bone metastases in lung cancer. Clin Calcium, 2008 [acceso 10/12/19];18:455-459. Disponible en: https://www.researchgate.net/publication/5473691_Bone_metastases_in_lung_cancer_article_in_Japanese

  18. Brown HK, Healey JH. Metastatic cancer to the bone. En: DeVita VT, Hellman S, Rosenberg S Editores. Cancer. Principles and practice of oncology. Philadelphia, Lippincott Williams and Wilkins, 2001[acceso 12/09/19];2713-2729. Disponible en: https://www.clinicaloncologyonline.net/article/S0936-6555(03)00113-4

  19. Centeno C, Sanz A. Metástasis óseas: manifestaciones clínicas y complicaciones. Un tratamiento multidisciplinar. Med Pal (Madrid). 2001 [acceso 18/05/2019];8(2):100-108. Disponible en: http://www.secpal.com/Documentos/Articulos/archivoPDF_42.pdf

  20. Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metástasis: An update J Radiol. 2015 [acceso 02/03/2020];7:202-211. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553252/

  21. Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, et al. Predicting bone scan positivity in non- metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2015 [acceso 02/01/2020];18:333-337. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640947/




2020     |     www.medigraphic.com